Pharmacological Management of Obesity in Patients with Type 2 Diabetes: An Update
Korean Journal of Obesity
; : 121-128, 2016.
Article
em En
| WPRIM
| ID: wpr-761666
Biblioteca responsável:
WPRO
ABSTRACT
Type 2 diabetes is closely linked with obesity. Obesity is associated with risk of both development and progression of type 2 diabetes, as well as cardiovascular disease. Although lifestyle modifications aimed at prompting weight reduction are cornerstone therapies in managing type 2 diabetes, weight reduction remains challenging for overweight and obese patients with type 2 diabetes. A shift in the approach to weight management in patients with type 2 diabetes is clearly needed. Pharmacotherapy should be considered as a realistic treatment option for patients with type 2 diabetes who cannot lose weight with health behavior modification alone. This review is focused on current pharmacotherapies for obesity to support the glycemic and weight loss goals of obese people with type 2 diabetes.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Doenças Cardiovasculares
/
Comportamentos Relacionados com a Saúde
/
Redução de Peso
/
Tratamento Farmacológico
/
Sobrepeso
/
Estilo de Vida
/
Obesidade
Limite:
Humans
Idioma:
En
Revista:
Korean Journal of Obesity
Ano de publicação:
2016
Tipo de documento:
Article